Citigroup’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.77K Sell
11,411
-31,786
-74% -$10.5K ﹤0.01% 4566
2025
Q1
$13.5K Sell
43,197
-5,354
-11% -$1.67K ﹤0.01% 4378
2024
Q4
$45.3K Buy
48,551
+4,599
+10% +$4.29K ﹤0.01% 4265
2024
Q3
$51.9K Buy
43,952
+29,636
+207% +$35K ﹤0.01% 4234
2024
Q2
$11K Buy
14,316
+2,864
+25% +$2.2K ﹤0.01% 4372
2024
Q1
$34.9K Buy
11,452
+1,426
+14% +$4.35K ﹤0.01% 4067
2023
Q4
$32.3K Buy
10,026
+9,997
+34,472% +$32.2K ﹤0.01% 4001
2023
Q3
$111 Sell
29
-17,729
-100% -$67.9K ﹤0.01% 4625
2023
Q2
$58.2K Buy
+17,758
New +$58.2K ﹤0.01% 3879
2023
Q1
Sell
-1,237
Closed -$2.3K 4871
2022
Q4
$2.3K Buy
1,237
+43
+4% +$80 ﹤0.01% 4437
2022
Q3
$2K Sell
1,194
-238
-17% -$399 ﹤0.01% 4709
2022
Q2
$3K Sell
1,432
-239
-14% -$501 ﹤0.01% 4996
2022
Q1
$5K Sell
1,671
-387
-19% -$1.16K ﹤0.01% 5008
2021
Q4
$7K Sell
2,058
-1,497
-42% -$5.09K ﹤0.01% 4842
2021
Q3
$12K Sell
3,555
-556
-14% -$1.88K ﹤0.01% 4663
2021
Q2
$16K Sell
4,111
-250
-6% -$973 ﹤0.01% 4751
2021
Q1
$18K Sell
4,361
-6,146
-58% -$25.4K ﹤0.01% 4655
2020
Q4
$24K Buy
10,507
+4,195
+66% +$9.58K ﹤0.01% 4526
2020
Q3
$36K Buy
6,312
+479
+8% +$2.73K ﹤0.01% 3647
2020
Q2
$43K Buy
5,833
+720
+14% +$5.31K ﹤0.01% 3846
2020
Q1
$15K Sell
5,113
-496,349
-99% -$1.46M ﹤0.01% 4492
2019
Q4
$2.08M Buy
501,462
+499,976
+33,646% +$2.07M ﹤0.01% 1642
2019
Q3
$5K Sell
1,486
-499
-25% -$1.68K ﹤0.01% 4788
2019
Q2
$4K Sell
1,985
-1,519
-43% -$3.06K ﹤0.01% 4931
2019
Q1
$7K Buy
3,504
+24
+0.7% +$48 ﹤0.01% 4826
2018
Q4
$9K Sell
3,480
-135
-4% -$349 ﹤0.01% 4657
2018
Q3
$20K Buy
+3,615
New +$20K ﹤0.01% 4516
2018
Q2
Sell
-1,522
Closed -$10K 5049
2018
Q1
$10K Buy
1,522
+1,009
+197% +$6.63K ﹤0.01% 4486
2017
Q4
$5K Buy
+513
New +$5K ﹤0.01% 4661
2017
Q3
Sell
-28,629
Closed -$301K 4819
2017
Q2
$301K Buy
+28,629
New +$301K ﹤0.01% 2703